Nonadherence, clinical inertia, or therapeutic inertia?
نویسندگان
چکیده
in which certain therapies have adequate, even overwhelming if not unequivocal, evidence of effectiveness.5 Clinical inertia occurs, for example, when the patient fails to attain a biomarker goal (e.g., blood pressure less than 140/90 millimeters of mercury [mm Hg]) due at least in part to failure to intensify pharmacotherapy through upward dosing and/or addition of drugs to the therapeutic regimen. O’Connor et al. attributed clinical inertia 50% to physician factors, 30% to patient factors, and 20% to office-system factors.4 We might consider the latter category even more broadly to include all health-system factors (Table 1). While we are uncertain about the relative weights for these 3 categories of factors that contribute to clinical inertia, we propose that this conceptual model, including relative weights, should become a focal point in research in nonadherence and failure to attain biomarker and other clinical goals. While acknowledging access, cost, and patient nonadherence, Phillips et al. emphasized the role of clinicians when they wrote in 2001 that clinical inertia occurs when health care providers recognize the problem (failure to attain therapeutic targets in patients with hypertension, dyslipidemia, or diabetes) but fail to act (to initiate or intensify therapy). Clinical inertia is more than failure to act, and it has been shown that other factors such as clinician communication affect adherence. Zolnierek and DiMatteo (2009) discovered in a meta-analysis of 127 studies that the odds of adherence for patients whose physicians had been trained in communication skills were 1.62 times those of patients whose physicians did not receive communication training.6
منابع مشابه
Therapeutic inertia in the outpatient management of dyslipidemia in patients with ischemic heart disease. The inertia study.
INTRODUCTION AND OBJECTIVES Studies indicate that dyslipidemia is undertreated. Numerous systematic reviews have shown that, even when therapeutic targets set by clinical practice guidelines have not been met, treatment remains unchanged despite the availability of alternatives approaches. The result is increased morbidity and mortality. Our aims were to investigate this phenomenon, known as th...
متن کاملTherapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review
AIMS Therapeutic inertia, defined as the failure to initiate or intensify therapy in a timely manner according to evidence-based clinical guidelines, is a key reason for uncontrolled hyperglycaemia in patients with type 2 diabetes. The aims of this systematic review were to identify how therapeutic inertia in the management of hyperglycaemia was measured and to assess its extent over the past d...
متن کاملThe concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review
BACKGROUND Therapeutic inertia has been defined as the failure of health-care provider to initiate or intensify therapy when therapeutic goals are not reached. It is regarded as a major cause of uncontrolled hypertension. The exploration of its causes and the interventions to reduce it are plagued by unclear conceptualizations and hypothesized mechanisms. We therefore systematically searched th...
متن کاملAuthor's response to reviews Title:The concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review Authors:
28 Background. Therapeutic inertia has been defined as the failure of health-care provider to 29 initiate or intensify therapy when therapeutic goals are not reached. It is regarded as a major 30 cause of uncontrolled hypertension. The exploration of its causes and the interventions to 31 reduce it are plagued by unclear conceptualizations and hypothesized mechanisms. We 32 therefore systematic...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of managed care pharmacy : JMCP
دوره 15 8 شماره
صفحات -
تاریخ انتشار 2009